Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.24.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2023
Jun. 30, 2023
Current assets:    
Cash and cash equivalents $ 5,804 $ 44,187
Accounts receivable 30,281 33,396
Inventory 133,371 276,202
Other current assets 133,410 92,726
Total current assets 302,866 446,511
Total assets 302,866 446,511
Current liabilities:    
Accounts payable and accrued liabilities 747,702 604,516
Convertible notes payable - net of discounts 2,196,981 1,491,719
Total current liabilities 3,105,584 2,198,111
Commitments and contingencies (Note 12)
Stockholders’ equity (deficit):    
Common stock, $0.001 par value, 200,000,000 shares authorized 127,221,301 and 123,587,968 issued and outstanding as of December 31, 2023 and June 30, 2023, respectively 127,221 123,588
Additional paid in capital 34,003,451 33,112,935
Accumulated deficit (36,933,393) (34,988,126)
Total Stockholders’ Equity (Deficit) (2,802,718) (1,751,600)
Total Liabilities and Stockholders’ Equity (Deficit) 302,866 446,511
Series A Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock 1 1
Series B Preferred Stock    
Stockholders’ equity (deficit):    
Series of preferred stock 2 2
Related party    
Current liabilities:    
Accounts payable and accrued liabilities - related party $ 160,901 $ 101,876